Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 4Terminated 3

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Neoplasm Metastasis 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1415Paclitaxel 1319Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1111Bevacizumab 1031Fluorouracil 895Doxorubicin 792Dexamethasone 748Rituximab 720Capecitabine 717Oxaliplatin 701pembrolizumab 680Etoposide 678Irinotecan 636Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 560Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 428Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × irosustat × Clear all
NCT01840488 2019-11-22

BN83495 Phase I in Post-menopausal Women

Ipsen

Phase 1 Completed
50 enrolled
Breast

Breast Neoplasms

NCT00910091 2019-01-30

The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer

Ipsen

Phase 2 Completed
73 enrolled 19 charts
Gynecologic

Endometrial Neoplasms

NCT00790374 2019-01-15

STX64PC

Ipsen

Phase 1 Completed
17 enrolled
Genitourinary

Prostatic Neoplasms

NCT01785992 2015-03-24

IRIS

Imperial College London

Phase 2 Completed
27 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡